Holen Sie sich die Stockscreener-App
14.08
4.93%
-0.73
Handel nachbörslich:
14.08
Schlusskurs vom Vortag:
$14.81
Offen:
$14.71
24-Stunden-Volumen:
1.43M
Relative Volume:
0.70
Marktkapitalisierung:
$2.17B
Einnahmen:
$276.98M
Nettoeinkommen (Verlust:
$-59.46M
KGV:
-35.31
EPS:
-0.3987
Netto-Cashflow:
$-48.95M
1W Leistung:
+9.57%
1M Leistung:
-5.25%
6M Leistung:
-2.70%
1J Leistung:
+88.49%
1-Tages-Spanne:
$14.05
$14.90
1-Wochen-Bereich:
$13.09
$14.90
52-Wochen-Spanne:
$6.7057
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Compare ADPT vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
14.08 | 2.28B | 276.98M | -59.46M | -48.95M | -0.3987 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-09-30 | Eingeleitet | Guggenheim | Buy |
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Affiliate sales disclosed for Adaptive Biotechnologies (NASDAQ: ADPT) in Form 144 - Stock Titan
Adaptive Biotechnologies Hits Day Low of $12.02 Amid Price Pressure - Markets Mojo
A Look At Adaptive Biotechnologies (ADPT) Valuation After Q4 2025 Beat And New Pfizer Agreements - Yahoo! Finance Canada
ADPT Technical Analysis & Stock Price Forecast - Intellectia AI
Adaptive Biotechnologies CSO Robins sells $799k in ADPT stock - Investing.com
Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock - Investing.com
Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares - MarketBeat
Adaptive Biotechnologies president sells $553,693 in ADPT stock - Investing.com
Adaptive Biotechnologies (ADPT) COO exercises options and sells 38K shares - Stock Titan
ADPT PE Ratio & Valuation, Is ADPT Overvalued - Intellectia AI
ADPT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Adaptive Biotechnologies (ADPT) president sells $751k in stock - Investing.com
Adaptive Biotech (NASDAQ: ADPT) COO sells 57,180 shares in 10b5-1 plan - Stock Titan
Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look - The Motley Fool
Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look - The Motley Fool
A Look At Adaptive Biotechnologies (ADPT) Valuation After Recent Share Price Weakness - simplywall.st
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Down 6.7%Here's What Happened - MarketBeat
Adaptive Biotechnologies’ president Rubinstein sells $802k in ADPT stock By Investing.com - Investing.com India
Adaptive Biotechnologies (ADPT) COO sells shares under Rule 10b5-1 plan - Stock Titan
Adaptive Biotechnologies’ president Rubinstein sells $802k in ADPT stock - Investing.com
[SCHEDULE 13G/A] Adaptive Biotechnologies Corp Amended Passive Investment Disclosure - Stock Titan
Adaptive Biotechnologies (ADPT) falls 24.5% as execs dispose millions of stake - MSN
Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year - Yahoo Finance
Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price - Yahoo Finance
Adaptive Biotechnologies (ADPT) president Rubinstein sells $769k in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares of Stock - marketbeat.com
Adaptive Biotechnologies (ADPT) president Rubinstein sells $769k in stock - Investing.com UK
Adaptive Biotechnologies (ADPT) COO sells 57K shares under 10b5-1 plan - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $255,594.60 in Stock - MarketBeat
Adaptive Biotechnologies COO Rubinstein sells $762k in ADPT stock By Investing.com - za.investing.com
Adaptive Biotechnologies COO Rubinstein sells $762k in ADPT stock - Investing.com
Adaptive Biotechnologies (ADPT) COO exercises options and sells 57,180 shares - Stock Titan
[144] Adaptive Biotechnologies Corp SEC Filing - Stock Titan
ADPT (NASDAQ: ADPT) lists 140,666 RSUs and 329,600 PSUs in Rule 144 filing - Stock Titan
[144] Adaptive Biotechnologies Co... | ADPT SEC FilingForm 144 - Stock Titan
18,672 RSUs registered for sale by filer (ADPT) via Morgan Stanley - Stock Titan
Chad Robins lists multiple ADPT share sales in Form 144 (ADPT) - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance
Adaptive Biotechnologies Corporation $ADPT Shares Sold by Braidwell LP - MarketBeat
Adaptive Biotechnologies CFO Piskel sells $245,910 in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CCO Bobulsky sells $544k in ADPT stock By Investing.com - Investing.com Australia
Insider Sell: Michelle Griffin Sells 15,394 Shares of Adaptive B - gurufocus.com
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CFO Sells 18,672 Shares of Stock - MarketBeat
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells 470,167 Shares of Stock - MarketBeat
Adaptive Biotechnologies’ president Rubinstein sells $2.37 million in ADPT stock - Investing.com
Adaptive Biotechnologies director Griffin sells $214,130 in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies director Griffin sells $214,130 in stock - Investing.com
Adaptive Biotechnologies Executives Sell Shares to Cover Tax Obligations - TradingView
Adaptive Biotechnologies’ chief scientific officer sells $6.19 million in stock By Investing.com - au.investing.com
Adaptive Biotechnologies CFO Piskel sells $245,910 in shares - Investing.com
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):